ArticleMolecular diversity2026
Integrated network toxicology and bioinformatics approaches explore potential mechanisms linking organophosphate flame retardant exposure to rheumatoid arthritis.
Article in Molecular diversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Organophosphate flame retardants (OPFRs) are emerging environmental pollutants characterized by high toxicity and persistence; however, their molecular links to rheumatoid arthritis (RA) remain poorly understood. This study employed an integrated approach combining network toxicology, machine learning, and molecular docking to elucidate potential associations between OPFR exposure and RA pathogenesis. By integrating data from multiple databases, we identified 39 overlapping targets associated with both OPFRs and RA. Functional enrichment analysis suggested that these genes were primarily involved in immune regulation and inflammatory responses, potentially through the Toll-like receptor (TLR), NOD-like receptor (NLR), IL-17, and p53 signaling pathways. Using machine learning algorithms, five hub genes-SDC1, SRD5A1, SPP1, COL4A3, and MMP13-were identified as critical biomarkers. Validation using independent Gene Expression Omnibus datasets confirmed their significant differential expression in RA tissues and robust discriminatory potential. Furthermore, Immune-cell infiltration analysis revealed significant correlations between these hub genes and immune cell infiltration, suggesting their potential roles in reshaping the immune microenvironment. Molecular docking and molecular dynamics (MD) simulations further demonstrated strong binding affinities and structural stability in interactions between OPFRs and the proteins encoded by these hub genes in silico. In conclusion, this study identified key genes potentially targeted by OPFRs that are also implicated in RA. These findings provide novel theoretical insights into the environmental risk assessment of OPFRs and identify potential targets for future experimental validation and therapeutic intervention in environmentally associated autoimmune disorders.
Indexed as
Identifiers
42530799What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.